{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:27Z","timestamp":1784204787208,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007670","name":"Dalhousie Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cbi.2024.111012","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:47:27Z","timestamp":1713667647000},"page":"111012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-\u03b2 plaques in human brain tissue"],"prefix":"10.1016","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-984X","authenticated-orcid":false,"given":"G.A.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-7761","authenticated-orcid":false,"given":"S.","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8000","key":"10.1016\/j.cbi.2024.111012_bib1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"4558","key":"10.1016\/j.cbi.2024.111012_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"4589","key":"10.1016\/j.cbi.2024.111012_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2024.111012_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2024.111012_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.cbi.2024.111012_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.cbi.2024.111012_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.cbi.2024.111012_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00005072-196507000-00008","article-title":"Enzyme histochemical studies of senile plaques. 1965","volume":"24","author":"Friede","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.cbi.2024.111012_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"6","key":"10.1016\/j.cbi.2024.111012_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ana.410220603","article-title":"Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles","volume":"22","author":"Mesulam","year":"1987","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.cbi.2024.111012_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","article-title":"Cholinesterases and the pathology of Alzheimer disease","volume":"9","author":"Geula","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"5","key":"10.1016\/j.cbi.2024.111012_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/156720510791383868","article-title":"Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues","volume":"7","author":"Darvesh","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(89)90419-8","article-title":"Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease","volume":"498","author":"Geula","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2024.111012_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1993.tb23029.x","article-title":"Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease","volume":"695","author":"Wright","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2225797","article-title":"A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer's disease","volume":"38","author":"Darvesh","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2024.111012_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.cbi.2024.111012_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia","volume":"36","author":"Mesulam","year":"1994","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.cbi.2024.111012_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.cbi.2024.111012_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-170164","article-title":"Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer's disease","volume":"58","author":"Macdonald","year":"2017","journal-title":"J. Alzheim. Dis."},{"issue":"6","key":"10.1016\/j.cbi.2024.111012_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"40","key":"10.1016\/j.cbi.2024.111012_bib23","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"Pt B","key":"10.1016\/j.cbi.2024.111012_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cbi.2016.04.022","article-title":"Reduced fibrillar \u03b2-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model","volume":"259","author":"Darvesh","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"12","key":"10.1016\/j.cbi.2024.111012_bib25","doi-asserted-by":"crossref","first-page":"2320.e15","DOI":"10.1016\/j.neurobiolaging.2010.04.028","article-title":"Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo","volume":"32","author":"Darreh-Shori","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"Pt 1","key":"10.1016\/j.cbi.2024.111012_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/brain\/awv318","article-title":"Amyloid-\u03b2 peptides act as allosteric modulators of cholinergic signalling through formation of soluble BA\u03b2ACs","volume":"139","author":"Kumar","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cbi.2024.111012_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.cbi.2024.111012_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"36","key":"10.1016\/j.cbi.2024.111012_bib29","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1021\/bi034768i","article-title":"The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers","volume":"42","author":"Cottingham","year":"2003","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.cbi.2024.111012_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001834","article-title":"Structural elements regulating amyloidogenesis: a cholinesterase model system","volume":"3","author":"Jean","year":"2008","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.cbi.2024.111012_bib31","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3\u20134","key":"10.1016\/j.cbi.2024.111012_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000113711","article-title":"Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro","volume":"5","author":"Podoly","year":"2008","journal-title":"Neurodegener. Dis."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2024.111012_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cbi.2010.01.003","article-title":"Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study","volume":"187","author":"Podoly","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"53","key":"10.1016\/j.cbi.2024.111012_bib34","first-page":"1","article-title":"The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome","volume":"10","author":"Drummond","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.cbi.2024.111012_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/1567205018666210827122704","article-title":"Interaction of exogenous butyrylcholinesterase with \u03b2-amyloid plaques in 5XFAD\/butyrylcholinesterase-knockout mouse brain","volume":"18","author":"Reid","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2024.111012_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110065","article-title":"Neuropathology and cholinesterase expression in the brains of octogenarians and older","volume":"364","author":"Maxwell","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.111012_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/12.3.219","article-title":"\u201cDirect-coloring\u201d thiocholine method for cholinesterases","volume":"12","author":"Karnovsky","year":"1964","journal-title":"J. Histochem. Cytochem."},{"issue":"9","key":"10.1016\/j.cbi.2024.111012_bib38","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","article-title":"Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors","volume":"29","author":"Lockridge","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"10","key":"10.1016\/j.cbi.2024.111012_bib39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","article-title":"Characterization of the low molecular weight human serum proteome","volume":"2","author":"Tirumalai","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"issue":"20","key":"10.1016\/j.cbi.2024.111012_bib40","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/rcm.3729","article-title":"Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis","volume":"22","author":"Kay","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.cbi.2024.111012_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jprot.2016.05.010","article-title":"A cost-effective method to get insight into the peritoneal dialysate effluent proteome","volume":"145","author":"Ara\u00fajo","year":"2016","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.cbi.2024.111012_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.talanta.2018.01.057","article-title":"Modulating the protein content of complex proteomes using acetonitrile","volume":"182","author":"Prates","year":"2018","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00712806","article-title":"Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme","volume":"11","author":"Velan","year":"1991","journal-title":"Cell. Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.cbi.2024.111012_bib44","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.cbi.2024.111012_bib45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"issue":"19","key":"10.1016\/j.cbi.2024.111012_bib46","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer's Res. Ther."},{"issue":"3\u20134","key":"10.1016\/j.cbi.2024.111012_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jlcr.3002","article-title":"PET probes for imaging brain acetylcholinesterase","volume":"56","author":"Kikuchi","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"21","key":"10.1016\/j.cbi.2024.111012_bib49","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1016\/j.bmc.2016.08.048","article-title":"Development of acetophenone ligands as potential neuroimaging agents for cholinesterases","volume":"24","author":"Jollymore-Hughes","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"5\u20136","key":"10.1016\/j.cbi.2024.111012_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0928-4257(99)80002-3","article-title":"Molecular interactions of acetylcholinesterase with senile plaques","volume":"92","author":"Inestrosa","year":"1998","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.cbi.2024.111012_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","article-title":"Role of acetylcholinesterase in \u03b2-amyloid aggregation studied by accelerated molecular dynamics","volume":"7","author":"Lushchekina","year":"2017","journal-title":"BioNanoSci"},{"issue":"1","key":"10.1016\/j.cbi.2024.111012_bib52","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","volume":"2006","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.cbi.2024.111012_bib53","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00228-022-03363-6","article-title":"Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews","volume":"78","author":"Majidazar","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.cbi.2024.111012_bib54","article-title":"Inhibition of human cholinesterases and in vitro \u03b2-amyloid aggregation by rationally designed peptides","volume":"18","author":"Sanchis","year":"2023","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.cbi.2024.111012_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021954","article-title":"Rivastigmine lowers A\u03b2 and increases sAPP\u03b1 levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons","volume":"6","author":"Bailey","year":"2011","journal-title":"PLoS One"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T12:50:04Z","timestamp":1716555004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":55,"alternative-id":["S0009279724001583"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-\u03b2 plaques in human brain tissue","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111012"}}